.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

AAN Conference Perspectives

Latest News

Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy

Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes

Antirituximab Antibodies Detected in Patients with Pemphigus

View More News

AAN Conference Perspectives

EP. 1: Multiple Sclerosis AAN Video Highlights

EP. 2: Tardive Dyskinesia AAN Video Highlights

EP. 3: Novel Alzheimer's disease Therapy to Slow Cognitive Decline?

EP. 4: The Unmet Needs in ALS Research: Diagnose, Treat Patients Earlier

EP. 5: What Are New Developments in Epilepsy Research?

EP. 6: Advancing Innovative Technology into Safe and Effective Medicines

EP. 7: Transforming The Approach to Epilepsy Treatment

EP. 8: The Effect of Disease Modifying Treatment In Multiple Sclerosis Patients

EP. 9: Treating Cluster Headaches with Non-Invasive Vagal Nerve Stimulator

EP. 10: Multiple Sclerosis: The Impact on Cortical Atrophy

Latest News